CENPA and systemic sclerosis: Overall, autoAbs to at least one of the three main SSc-associated anti-TopoI (Scl-70), anti-CENP (CENPA or CENPB) or anti-RNApol III (RP11 and/or RP155) autoAbs were present in 125 (79.1%) SSc patients.